Global Healthcare IT Consulting Market

1 INTRODUCTION OF GLOBAL HEALTHCARE IT CONSULTING MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL HEALTHCARE IT CONSULTING MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL HEALTHCARE IT CONSULTING MARKET, BY TYPE
5.1 Overview
5.2 HCIT Strategy and Project/Program Management
5.3 Healthcare application
5.4 HCIT Change Management
5.5 Healthcare systems Risk Assessment
5.6 Healthcare Enterprise Reporting and Data Analytics
5.7 Product Go-live Support
5.8 Healthcare Business Process Management
5.9 Regulatory Compliance
5.10 Other Consulting Services

6 GLOBAL HEALTHCARE IT CONSULTING MARKET, BY END-USER
6.1 Overview
6.2 Healthcare Providers
6.2.1 Hospitals, Physician groups and Integrated Delivery
6.2.2 Ambulatory Care Centres
6.2.3 Diagnostic and Imaging Centres
6.2.4 Healthcare Agencies, Nursing homes and Living Facilities
6.2.5 Others
6.3 Healthcare Payers
6.4 Others

7 GLOBAL HEALTHCARE IT CONSULTING MARKET, BY GEOGRAPHY
7.1 Overview
7.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
7.2.1 U.S.
7.2.2 Canada
7.2.3 Mexico
7.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
7.3.1 Germany
7.3.2 U.K.
7.3.3 France
7.3.4 Rest of Europe
7.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Rest of Asia Pacific
7.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
7.5.1 Brazil
7.5.2 Argentina
7.6 Rest of the World Regional Market Estimates and Forecasts, 2012 - 2025

8 GLOBAL HEALTHCARE IT CONSULTING MARKETCOMPETITIVE LANDSCAPE
8.1 Overview
8.2 Company Market Share
8.3 Vendor Landscape
8.4 Key Development Strategies

9 COMPANY PROFILES
9.1 Koninklijke Philips N.V.
9.1.1 Overview
9.1.2 Financial Performance
9.1.3 Product Outlook
9.1.4 Key Developments

9.2 IBM Corporation
9.2.1 Overview
9.2.2 Financial Performance
9.2.3 Product Outlook
9.2.4 Key Developments

9.3 General Electric (GE) Company Waters Corporation
9.3.1 Overview
9.3.2 Financial Performance
9.3.3 Product Outlook
9.3.4 Key Developments

9.4 Siemens Healthineers
9.4.1 Overview
9.4.2 Financial Performance
9.4.3 Product Outlook
9.4.4 Key Developments

9.5 Cerner Corporation Perkinelmer Inc.
9.5.1 Overview
9.5.2 Financial Performance
9.5.3 Product Outlook
9.5.4 Key Developments

9.6 Mckesson Corporation
9.6.1 Overview
9.6.2 Financial Performance
9.6.3 Product Outlook
9.6.4 Key Developments

9.7 NTT Data Corporation
9.7.1 Overview
9.7.2 Financial Performance
9.7.3 Product Outlook
9.7.4 Key Developments

9.8 Allscripts Healthcare Solutions, Inc.
9.8.1 Overview
9.8.2 Financial Performance
9.8.3 Product Outlook
9.8.4 Key Developments

9.9 Deloitte Touche Tohmatsu Limited
9.9.1 Overview
9.9.2 Financial Performance
9.9.3 Product Outlook
9.9.4 Key Developments

9.10 Epic Systems Corporation
9.10.1 Overview
9.10.2 Financial Performance
9.10.3 Product Outlook
9.10.4 Key Developments

9.11 Cognizant
9.11.1 Overview
9.11.2 Financial Performance
9.11.3 Product Outlook
9.11.4 Key Development

9.12 Infor, Inc.
9.12.1 Overview
9.12.2 Financial Performance
9.12.3 Product Outlook
9.12.4 Key Development
9.13 Oracle
9.13.1 Overview
9.13.2 Financial Performance
9.13.3 Product Outlook
9.13.4 Key Development

9.14 Accenture
9.14.1 Overview
9.14.2 Financial Performance
9.14.3 Product Outlook
9.14.4 Key Development

10 Appendix
10.1 Related Reports